NIH Research to Address the Real-Life Challenges of Opioid CrisisClear ScientificMay 13, 20221 min readUpdated: Jun 16, 2022Atlanta, GA | May 2022https://directorsblog.nih.gov/2022/05/10/rx-and-illicit-drug-summit-a-conversation-on-helping-people-and-families-in-need/
FDA Grants Fast Track Designation for CS-1103, a First-in-class Small Molecule to Reverse Acute Intoxication from MethamphetamineCambridge, MA | September 2025 PRNewswire / -- Clear Scientific Inc., a clinical stage biopharmaceutical company focused on the...
Clear Scientific Inc’s General Counsel, Winston Henderson, Joins Expert Panel on Tackling Substance Use DisordersBoston, MA | July 2025 On July 31, Winston Henderson, General Counsel at Clear Scientific Inc., joined a panel with Carl Berke (Mass...
Clear Scientific Presents at 87th Annual Scientific Meeting of the College on Problems of Drug DependenceNew Orleans, Louisiana | June 2025 On June 16, 2025, Piercen Oliver PhD, VP of R&D and Xinhua Li PhD, Executive Vice President Drug...
Comments